Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
ZIPDOSE
Su - Non-Final Action - Mailed
Show more
Development of pharmaceutical and nutraceutical preparations for others, namely, pharmaceutical and nutraceutical compounds in a unitary solid dosage form for the rapid dispersion of a wide variety of therapeutic agents; research and development in the pharmaceutical and nutraceutical fields for others, namely, research and development of pharmaceutical and nutraceutical compounds in a unitary solid dosage form for the rapid dispersion of a wide variety of therapeutic agents
Class 42 – Technology & SaaS
Status timeline
- 3 Nov 2023Application filedNew Application Entered
- 9 May 2024Assigned to an examining attorneyAssigned To Examiner
- 9 May 2024Office action issuedNon-Final Action Written
- 28 May 2024Response to office action filedTeas Response To Office Action Received
- 26 Nov 2024Office action issuedNon-Final Action Written
- 21 Feb 2025Response to office action filedTeas Response To Office Action Received
- 27 Mar 2025Approved for publicationApproved For Pub - Principal Register
- 22 Apr 2025Published for oppositionPublished For Opposition
- 17 Jun 2025Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 15 Dec 2025Statement of use filedTeas Statement Of Use Received
- 12 May 2026Statement-of-use extension 1 grantedSou Extension 1 Granted
- 25 Jun 2026Office action issuedNon-Final Action Written
All 38 events
| 2026-06-25 | Non-Final Action Written |
| 2026-06-25 | Non-Final Action E-Mailed |
| 2026-06-25 | Notification Of Non-Final Action E-Mailed |
| 2026-05-13 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-05-12 | Case Assigned To Intent To Use Paralegal |
| 2026-05-12 | Sou Extension 1 Granted |
| 2026-05-12 | Statement Of Use Processing Complete |
| 2025-12-15 | Teas Statement Of Use Received |
| 2025-12-15 | Sou Teas Extension Received |
| 2025-12-15 | Use Amendment Filed |
| 2025-12-14 | Sou Extension 1 Filed |
| 2025-06-17 | Noa Mailed - Sou Required From Applicant |
| 2025-04-22 | Published For Opposition |
| 2025-04-22 | Official Gazette Publication Confirmation E-Mailed |
| 2025-04-16 | Notification Of Notice Of Publication E-Mailed |
| 2025-03-27 | Approved For Pub - Principal Register |
| 2025-03-12 | Teas Change Of Owner Address Received |
| 2025-03-12 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2025-03-12 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2025-03-12 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2025-03-12 | Teas Change Of Correspondence Received |
| 2025-03-12 | Teas Withdrawal Of Attorney Received-Firm Retains |
| 2025-02-21 | Teas Response To Office Action Received |
| 2025-02-21 | Correspondence Received In Law Office |
| 2025-02-21 | Teas/Email Correspondence Entered |
| 2024-11-26 | Non-Final Action Written |
| 2024-11-26 | Non-Final Action E-Mailed |
| 2024-11-26 | Notification Of Non-Final Action E-Mailed |
| 2024-09-26 | Assigned To Lie |
| 2024-09-26 | Correspondence Received In Law Office |
| 2024-09-26 | Teas/Email Correspondence Entered |
| 2024-05-28 | Teas Response To Office Action Received |
| 2024-05-09 | Assigned To Examiner |
| 2024-05-09 | Non-Final Action Written |
| 2024-05-09 | Non-Final Action E-Mailed |
| 2024-05-09 | Notification Of Non-Final Action E-Mailed |
| 2023-11-09 | New Application Office Supplied Data Entered |
| 2023-11-03 | New Application Entered |
Goods & services by class
Class 42 Technology & SaaS
Development of pharmaceutical and nutraceutical preparations for others, namely, pharmaceutical and nutraceutical compounds in a unitary solid dosage form for the rapid dispersion of a wide variety of therapeutic agents; research and development in the pharmaceutical and nutraceutical fields for others, namely, research and development of pharmaceutical and nutraceutical compounds in a unitary solid dosage form for the rapid dispersion of a wide variety of therapeutic agents
First use anywhere 30 Jul 2018 · First use in commerce 30 Jul 2018
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 25 Jun 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.